Role of pharmacodiagnostic of CYP2C9 variants in the optimization of warfarin therapy in Malaysia: a 6-month follow-up study

by Ngow, Harris Abdullah, Teh , Lay Kek, Langmia, I. M., Lew, W. L., Harun, R., Ismail, R., Salleh, Mohd Zaki
Published 2008

Clinical relevance of VKORC1 (G-1639A and C1173T) and CYP2C9*3 among patients on warfarin

by Teh, L. K., Langmia, I. M., M. H., Fazleen Haslinda, Ngow, Harris Abdullah, Roziah, M. J., Harun, R., Zakaria, Z. A., Salleh, M. Z.
Published 2011